Progress, evolving therapeutic/diagnostic approaches, and challenges in the management of hepatitis C virus infections
Author:
Publisher
Springer Science and Business Media LLC
Subject
Virology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00705-022-05375-0.pdf
Reference149 articles.
1. Keikha M, Eslami M, Yousefi B, Ali-Hassanzadeh M, Kamali A, Yousefi M, Karbalaei M (2020) HCV genotypes and their determinative role in hepatitis C treatment. Virus Dis 31(3):235–240. https://doi.org/10.1007/s13337-020-00592-0 (PMID: 32904762 PMCID: PMC7459022)
2. Farci P, Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (2002) Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome [Science 1989; 244:359–362]. J Hepatol 36(5):582–585. https://doi.org/10.1016/s0168-8278(02) (PMID. 11983439; Vol. 00051-x)
3. Alzahrani N, Wu MJ, Shanmugam S, Yi M (2020) Delayed by design: role of suboptimal signal peptidase processing of viral structural protein precursors in Flaviviridae virus assembly. Viruses. https://doi.org/10.3390/v12101090 (PMID: 32993149 PMCID: PMC7601889)
4. Stasi C, Silvestri C, Voller F (2020) Update on hepatitis C epidemiology: unaware and untreated infected population could be the key to elimination. SN Compr Clin Med. 2:2808–2815. https://doi.org/10.1007/s42399-020-00588-3
5. Mukhopadhya A (2006) HCV: the Indian scenario. Trop Gastroenterol 27(3):105–110 (PMID 17310552)
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Incidence of Liver and Non-liver Cancers After Hepatitis C Virus Eradication: A Population-Based Cohort Study;Drugs - Real World Outcomes;2024-06-14
2. Real-world treatment outcome of direct-acting antivirals and patient survival rates in chronic hepatitis C virus infection in Eritrea;Scientific Reports;2023-11-27
3. The Seroprevalence of Hepatitis C Virus (HCV) in Hemodialysis Patients in Oman: A National Cross-Sectional Study;Journal of Epidemiology and Global Health;2023-09-12
4. Alpha-mangostin, piperine and beta-sitosterol as hepatitis C antivirus (HCV): In silico and in vitro studies;Heliyon;2023-09
5. TASL, TADE, and DAROC consensus for the screening and management of hepatitis C in patients with diabetes;Journal of the Formosan Medical Association;2023-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3